Biosensis offers the highest quality primary antibodies for use in your apoptosis research. We offer over 20 antibodies in the apoptosis research area including antibodies against p53, apoptosis inhibitor 5, caspase-3, caspase-8 and FAS. Biosensis antibodies can be used in many applications including ELISA, western blot (WB) and immunohistochemistry (IHC).
Apoptosis is the process of programmed cell death. The study of apoptosis and cancer are quite closely linked because in the disease state the cancer cells have found a way to avoid apoptosis.